Miller, Miles C.

RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease

Donahue, J. E., Flaherty, S. L., Johanson, C. E., Duncan, J. A., Silverberg, G. D., Miller, M. C., Tavares, R., Yang, W., Wu, Q., Sabo, E., et al. (2006) · Acta Neuropathologica

Alzheimer's disease research and treatmentsAdvanced Glycation End Products research

Cited by 519

Hippocampal RAGE immunoreactivity in early and advanced Alzheimer’s disease

Miller, M. C., Tavares, R., Johanson, C. E., Hovanesian, V., Donahue, J. E., Gonzalez, L., Silverberg, G. D., & Stopa, E. G. (2008) · Brain Research

Advanced Glycation End Products researchAlzheimer's disease research and treatments

Cited by 194

Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging

Silverberg, G. D., Messier, A. A., Miller, M. C., Machan, J. T., Majmudar, S. S., Stopa, E. G., Donahue, J. E., & Johanson, C. E. (2010) · Journal of Neuropathology & Experimental Neurology

Alzheimer's disease research and treatmentsBarrier Structure and Function Studies

Cited by 191

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits

Izzo, N. J., Staniszewski, A., To, L., Fa, M., Teich, A. F., Saeed, F., Wostein, H., Walko, T., Vaswani, A., Wardius, M., et al. (2014) · PLoS ONE

Alzheimer's disease research and treatmentsPharmacological Receptor Mechanisms and Effects

Cited by 180

Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier

Osgood, D., Miller, M. C., Messier, A. A., Gonzalez, L., & Silverberg, G. D. (2017) · Neurobiology of Aging

Barrier Structure and Function StudiesDrug Transport and Resistance Mechanisms

Cited by 63